Status:
COMPLETED
Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment Decisions
Lead Sponsor:
GlaxoSmithKline
Collaborating Sponsors:
Institut Dr. Schauerte (IDS)
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
35+ years
Brief Summary
This study will evaluate the diagnostic measures (including blood eosinophil counts) commonly used by lung specialist's in routine clinical care of subjects with COPD in Germany and how these diagnost...
Eligibility Criteria
Inclusion
- For participating centers (Sample 1: 30 lung specialists from Germany)
- More than 10 years of experience in respiratory medicine
- At least 500 subjects under supervision in hospital- or office-based setting: a) Focus on obstructive lung diseases. b) Board certification. c) Informed consent to participate in this study and to share files of consenting subjects.
- For subjects (Sample 2: 250 COPD subjects from these 30 doctors from sample 1)
- Written informed consent to use his/her data.
- Age \>=40 years
- Pack years \>10, current or former smoking
- Duration of COPD: \>=1 year since COPD diagnosis record in subject files (also confirmed by spirometry)
- No concurrent asthma diagnosis
- At least one year of documented disease history at participating study doctors and have to be under the care of the before mentioned physician during this time because of COPD.
Exclusion
- Subjects who are pregnant and breastfeeding (in the last 12 months)
- Subjects currently participating in any interventional study
- Subjects with severe comorbidities which would have influence on the COPD therapy
Key Trial Info
Start Date :
April 19 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2018
Estimated Enrollment :
251 Patients enrolled
Trial Details
Trial ID
NCT03465332
Start Date
April 19 2018
End Date
August 30 2018
Last Update
January 15 2019
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Bruchsal, Baden-Wurttemberg, Germany, 76646
2
GSK Investigational Site
Ulm, Baden-Wurttemberg, Germany, 89073
3
GSK Investigational Site
Garmisch-Partenirchen, Bavaria, Germany, 82467
4
GSK Investigational Site
Nuremberg, Bavaria, Germany, 90489